Butyric Acid

Butyric Acid

SCHEMBL723850

CCCC(=O)O.OCC(CO)(CO)CO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.68
HDAC3 O15379 1/20 0.68
HDAC1 Q13547 1/20 0.68
HDAC2 Q92769 1/20 0.68
HDAC8 Q9BY41 1/20 0.68
AKR1B1 P15121 1/20 0.46
GPR84 Q9NQS5 7/20 0.44
PPARG P37231 7/20 0.44
PPARD Q03181 7/20 0.44
PPARA Q07869 7/20 0.44
HDAC11 Q96DB2 5/20 0.44
TSHR P16473 4/20 0.44
PTPN1 P18031 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
KMT2A Q03164 2/20 0.44
FFAR4 Q5NUL3 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL812956 1.00 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL8863608 1.00 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL27927290 1.00 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL2778941 1.00 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL11816294 1.00 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL8863585 0.95 FFAR3 (0.62) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL11357282 0.90 FFAR3 (0.62) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL813982 0.90 FFAR3 (0.62) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL30645321 0.89 FFAR3 (0.54) FFAR3HDAC3HDAC1HDAC2HDAC8
Hexanoate SCHEMBL11806349 0.89 AKR1B1 (0.67) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119684896-A Hardening liquid composition and hardening type transparent optical nylon 捷科冉(厦门)新材料有限公司 2025-03-25 CN disclosed
CN-112080531-B Preparation method of pentaerythritol monocarboxylic ester plasticizer and application of plasticizer in medical PVC (polyvinyl chloride) product 山东吉青化工有限公司 2023-08-08 CN disclosed
EP-3814422-B1 UV-CURABLE COMPOSITION AND ADHESIVE FILM, ADHESIVE TAPE AND BONDING MEMBER CONTAINING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-01-04 EP disclosed
US-11479621-B2 UV-curable composition and adhesive film, adhesive tape and bonding member containing the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-10-25 US disclosed
US-20210363276-A1 UV-CURABLE COMPOSITION AND ADHESIVE FILM, ADHESIVE TAPE AND BONDING MEMBER CONTAINING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-11-25 US disclosed
CN-112080531-A Preparation method of pentaerythritol monocarboxylic ester plasticizer and application of pentaerythritol monocarboxylic ester plasticizer in medical PVC (polyvinyl chloride) products 山东吉青化工有限公司 2020-12-15 CN disclosed
US-10815361-B2 Non-phthalic plasticiser PERSTORP AB (SE) 2020-10-27 US disclosed
US-10428194-B2 Modified acrylic resin cured product, and laminate thereof, and production methods therefor MITSUI CHEMICALS, INC. (JP) 2019-10-01 US disclosed
EP-2609148-B1 NON-PHTHALIC PLASTICISER PERSTORP AB (SE) 2019-09-25 EP disclosed
EP-3263635-B1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR MITSUI CHEMICALS INC (JP) 2019-09-18 EP disclosed
WO-2012026861-A1 NON-PHTHALIC PLASTICISER PERSTORP AB (SE) 2012-03-01 WO disclosed
EP-0765862-B1 FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL KAO CORP (JP) 2000-03-08 EP disclosed
US-5932755-A Fatty acid ester of etherified polyhydric alcohol KAO CORPORATION (JP) 1999-08-03 US disclosed
US-5661181-A Non-cyclic esters for pest control CORNELL RESEARCH FOUNDATION, INC. (US) 1997-08-26 US disclosed
EP-0765862-A1 FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL Kao Corporation (JP) 1997-04-02 EP disclosed
EP-0123679-A1 ESTERS OF RETINOIC ACID AND PENTAERYTHRITOL AND MONOBENZAL ACETALS THEREOF SRI INTERNATIONAL (US) 1984-11-07 EP disclosed
US-4464389-A SKIN DISORDERS, ANTITUMOR AGENTS SRI INTERNATIONAL (US) 1984-08-07 US disclosed
WO-1984001573-A1 ESTERS OF RETINOIC ACID AND PENTAERYTHRITOL AND MONOBENZAL ACETALS THEREOF STANFORD RES INST INT (US) 1984-04-26 WO disclosed
US-4275174-A METHYL METHACRYLATE-STYRENE COPOLYMER FORMED IN THE PRESENCE OF A POLYOL BORIC ACID ESTER KYOWA GAS CHEMICAL INDUSTRY CO., LTD. (JP) 1981-06-23 US disclosed
US-3952059-A Alkyl ammonium thiocyanate manufacture and lube containing same TEXACO INC. (US) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815361-B2 Non-phthalic plasticiser TPD52L2, MDM4, VPS4B FFAR3 492/4885HDAC3 2597/4885HDAC1 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.